AMSTERDAM (Reuters) - The European Medicines Agency said on Tuesday that if its experts have received enough data from drugmakers Pfizer and Moderna about their candidate vaccines against the coronavirus, the agency would complete its reviews by Dec. 29 and Jan. 12, respectively, at latest.
The companies said earlier on Tuesday that they had submitted approval requests for their vaccine candidates to the European drugs regulator.
Reporting by Toby Sterling. Editing by Jane Merriman
Our Standards: The Thomson Reuters Trust Principles.